Niagen Bioscience Inc logo NAGE - Niagen Bioscience Inc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 5
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $10.50 DETAILS
HIGH: $11.00
LOW: $10.00
MEDIAN: $10.50
CONSENSUS: $10.50
UPSIDE: 186.89%

Profitability Ratios

Ratio Value
GP Margin 64.3%
EBIT Margin 11.0%
EBITDA Margin 12.2%
Operating Margin 11.0%
Pretax Margin 14.1%
Cont. Ops Margin 13.4%
Net Margin 13.4%
Bottom Line Margin 13.4%

Liquidity Ratios

Ratio Value
Current Ratio 4.86
Quick Ratio 3.83
Solvency Ratio 0.630
Cash Ratio 3.25

Valuation Ratios

Ratio Value
Price/Earnings
28.97
Hist. avg: 41.0
Peers avg: 20.2
PEG Ratio 0.24
Forward PEG 0.24
Price/Book 6.58
Price/Sales 3.89
Price/FCF 38.31
Price/Op Cash Flow 37.48

Debt Ratios

Ratio Value
Debt/Assets 0.0265
Debt/Equity 0.0368
Debt/Capital 0.0355
Long-Term Debt/Capital 0.0000
Financial Leverage 1.39

Cash Flow Ratios

Ratio Value
Working Capital Turnover 2.10
Operating Cash Flow Ratio 0.675
Operating Cash Flow/Sales 10.4%
Free Cash Flow/Operating Cash Flow 97.8%

Coverage Ratios

Ratio Value
Debt Service Coverage 14.91
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 13.41
Operating Cash Flow Coverage 4.77
Capital Expenditure Coverage 46.02
Dividend + Capital Expenditure Coverage 46.02

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 1.63
EPS 0.220
Debt/Share 0.0356
Cash/Share 0.82
Book Value/Share 0.97
Tangible BV/Share 0.90
Equity/Share 0.97
Operating Cash Flow/Share 0.170
Capital Expenditure/Share 0.004
FCF/Share 0.166

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.955
Earnings Before Tax/EBIT 1.273
Price/Fair Value 6.58
Debt/Market Cap 0.0020
Effective Tax Rate 4.5%
Enterprise Value Multiple 28.05